Faget Quoted in Politico on Massachusetts Push for Telehealth Parity
February 5, 2019
Politico
Special Counsel Kyle Faget was quoted in Politico’s Morning eHealth newsletter about Massachusetts Bill HD3057 which puts reimbursement for telehealth services on par with in-person appointments.
Lawmakers appear to be “revitalizing” their push for coverage parity, Faget said. If passed, such measures could “open the gateway for telemedicine in Massachusetts.” Unlike more rural states that have already made it easier for remote patients to get coverage for virtual treatment, Massachusetts is “constantly criticized by everybody for failing to be a pioneer in the telemedicine landscape.”
(Subscription required.)
Lawmakers appear to be “revitalizing” their push for coverage parity, Faget said. If passed, such measures could “open the gateway for telemedicine in Massachusetts.” Unlike more rural states that have already made it easier for remote patients to get coverage for virtual treatment, Massachusetts is “constantly criticized by everybody for failing to be a pioneer in the telemedicine landscape.”
(Subscription required.)
People
Related News
June 10, 2025
In the News
Lynn Gandhi Sheds Light on Supreme Court Tax Ruling
Foley partner Lynn Gandhi commented in the Bloomberg Tax article "High Court’s Catholic Charities Case to Go Beyond Unemployment," sharing insight on the implications of the recent Supreme Court ruling in a tax case.
June 10, 2025
In the News
James McFall Joins Iconic Athletes and Leaders in Launch of Stanford Football Alumni United
Foley & Lardner LLP is proud to announce that partner James Carlos McFall is a founding member of Stanford Football Alumni United (SFAU), a newly formed coalition of former players and leaders committed to supporting Stanford Football’s continued growth and national competitiveness.
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."